Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Mitochondria-targeted magnolol inhibits OXPHOS, proliferation, and tumor growth via modulation of energetics and autophagy in melanoma cells

Cancer Treatment and Research Communications(2020)10.1016/j.ctarc.2020.100210Source: DataRank Database

Mitochondria-targeted magnolol inhibits OXPHOS, proliferation, and tumor growth via modulation of energetics and autophagy in melanoma cells is a research paper published in Cancer Treatment and Research Communications (2020). On theSindex it has a DataRank of 0. It has been cited 30 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access30 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: goldTopics (21)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Micaël Hardy ORCID,Jacek Zielonka ORCID,Katherine M. Weh ORCID,Monika Zielonka,Kathleen A. Boyle

Live enrichment

PubMed:21097893

National Institutes of Health

Grant: R01 CA226279

National Institutes of Health

Grant: U01 CA178960

National Science Foundation

Grant: CHE-1532168

National Science Foundation

Grant: 1532168

MRI: Upgrade of an EPR Spectrometer to Serve Marquette University and the Greater Milwaukee Region

National Institutes of Health

Grant: 5U01CA178960-02

Targeting pancreatic cancer energy metabolism, tumor growth, and metastasis

National Institutes of Health

Grant: 5R01CA226279-05

Biased chemokine receptor signaling in cancer progression

goldLicense: cc-by-nc-nd

publisherhttps://doi.org/10.1016/j.ctarc.2020.100210

publisherhttps://api.elsevier.com/content/article/PII:S2468294220300460?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2468294220300460?httpAccept=text/plain

repositoryhttps://doaj.org/article/39fdb841981f481cb80f9c25c3e0961d

repositoryhttp://europepmc.org/pmc/articles/PMC7883397

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Biphenyl CompoundsMitophagyNeoplasms. Tumors. Oncology. Including cancer and carcinogensMice, NudeArticleLignansOxidative PhosphorylationMiceCytoprotectionCell Line, TumorBioenergetic metabolismAutophagyAnimalsHumansNitric Oxide SynthaseMelanomaRC254-282Mitochondria-targeted agents

Sustainable Development Goals

SDG 3: 3. Good health